Most Recent Articles by Bryant Furlow
Overly aggressive or futile care at the end of a patient's life is particularly costly, both in dollars and in terms of patients' quality of life.
Cancer Therapy Advisor asked Dr Roberts about the PGen Study and the implications for DTC cancer risk testing in the future.
Gabapentin enacarbil was associated with lower incidences of peripheral edema and weight gain than pregabalin, according to authors of a multicenter, randomized, placebo-controlled Phase 2 study.
Fewer than 2% of prescribers behave criminally. But those 2% are responsible for more than 90% of law enforcement activity on prescription drug diversion.
Pain producers include, but are not limited to, viral and bacterial causes, as well as aseptic inflammation, pressure due to neoplasm or other structural lesions, and endocrine/metabolic mechanisms.
More Articles by Bryant Furlow
Clinical Pain Advisor Articles
- Sustained-Release Sodium Nitrite for Diabetic Neuropathic Pain Not Associated With Headaches
- Treatment for Opioid Use Disorder Associated With Reduced Risk for Opioid-Related Deaths
- Deaths After Nonfatal Opioid Overdose: Causes and Risk Factors
- Clonidine May Not Improve Post-Cesarean Delivery Analgesia
- No Added Value With Liposomal Bupivacaine Following TKA With Peripheral Nerve Block
- Recommendations for Perioperative Pain Management in Patients With Opioid Tolerance
- Vertebroplasty Comparable With Placebo for Acute Vertebral Compression Fractures
- Capsaicin 8% Patch May Be Effective in Neuropathic Pain
- Detox vs Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Expert Roundtable
- Prior Authorization Policy May Help Reduce Long-Acting Opioid Use
- Opioid-Related Deaths Represent Significant Public Health Burden
- Addressing Confidentiality Concerns With Electronic Access to Pediatric Medical Records
- Opioid-Related Adverse Events Common After Invasive Procedures
- Diagnosis and Treatment of Migraine in Children Should Consider Atopy
- Led by AG Sessions, DOJ Declines to Defend ACA Against Federal Lawsuit